Latest Regulatory News

Magnetite Mines has cleared a crucial regulatory hurdle as its Razorback Iron Ore Project’s Mining Lease Proposal passes the South Australian Government’s validity assessment, paving the way for detailed technical review and public consultation.

Metroglass has reported a 5% revenue decline in its half-year results but achieved a significant reduction in net debt and improved profitability, signaling progress in its turnaround strategy amid challenging market conditions.

Brightstar Resources outlines a bold growth strategy targeting over 200,000 ounces of annual gold production by 2029, leveraging its Western Australian assets and aggressive drilling programs. The company’s recent feasibility studies and acquisitions position it as a rising gold producer in the region.

Elementos Limited has announced a $2.9 million non-renounceable entitlement offer alongside a $6 million initial placement to fund key project developments, including the Oropesa Tin Project and Cleveland Tin and Tungsten Project.

Dusk Group Limited has addressed an ASX compliance query regarding the delayed disclosure of a director’s interest change, attributing the lapse to an administrative oversight while reaffirming its commitment to regulatory compliance.

Gold Hydrogen Limited has confirmed elevated levels of natural hydrogen and helium at its Ramsay 3 well, marking a significant step in its 2025 drilling campaign and reinforcing the potential of its South Australian project.

Cauldron Energy Limited addresses a sharp share price rise, attributing it to strong uranium exploration results and market speculation linked to a sector takeover.

Austral Gold has received TSX Venture Exchange approval to issue 1,025,077 shares as repayment of accrued interest on convertible notes, following a recent principal conversion. This move reflects ongoing capital management efforts amid the company’s growth strategy.

Infini Resources Limited’s I88OA securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Cynata Therapeutics has completed the final patient visit in its Phase 3 trial for CYP-004, targeting knee osteoarthritis, with results expected in mid-2026. This milestone advances hopes for a disease-modifying therapy in a market desperate for new options.

Redcastle Resources and BML Ventures have submitted a critical Mine Development and Closure Plan for their Queen Alexandra and Redcastle Reef deposits, setting the stage for gold production to commence in early 2026.

St George Mining reports outstanding high-grade rare earth and niobium assay results from its Araxá Project in Brazil, signaling a significant resource expansion and upgrade. Ongoing drilling suggests the deposit remains open in all directions, reinforcing Araxá’s status as a world-class asset.